What You Should Know:
– Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight…
Continue Reading
Lee Miller, Deputy Chief Architect, Juno Health
Patients may be seen by various doctors and clinicians during treatment, such as a primary care physician who diagnoses diabetes and monitors overall health, an endocrinologist who adjusts…
Continue Reading
Digital health diagnostics company PocDoc has announced the launch of a smartphone-based test for type 2 diabetes risk.
The test is being piloted in the north east of England and North Cumbria as part of…
What You Should Know:
– FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring…
Continue Reading
What You Should Know:
– Humana Inc. and health technology company DrFirst have announced a new program designed to close gaps in care for patients with chronic conditions like diabetes and cardiovascular disease.
– The program…
Continue Reading
Welcome to the July edition of Digital Health Digest!This month, we bring you the latest in healthcare innovation—from regulatory updates and groundbreaking partnerships to major funding milestones and inclusive health products. Stay tuned as…
Continue Reading
What You Should Know:
– The Gates Foundation announced a $2.5B commitment through 2030 to accelerate research and development (R&D) focused exclusively on women’s health.
– The investment will support the advancement of more than 40…
Continue Reading
Mark Clements, M.D., Ph.D. Chief Medical and Strategy Officer, Glooko
As healthcare providers, we find ourselves at an exciting crossroads in diabetes management. Rapid advancements in technology—from remote patient monitoring to artificial intelligence—have fundamentally altered…
Continue Reading
Engaging patients in the digital collection of electronic patient-reported outcome measures (ePROMs) and experience measures (ePREMs) is desirable for equitable, patient-centred chronic disease management; however, adherence remain unclear. This study examined demographic and socioeconomic…
Continue Reading
What You Should Know:
– Fangzhou Inc., a leader in Internet healthcare solutions announced a strategic collaboration with Novo Nordisk, a leading global healthcare company.
– The Memorandum of Understanding (MOU) was signed at the 3rd…
Continue Reading
